Survivin was considered as a target gene in cancer therapy, and down-regulation of Survivin could suppress tumor growth and improve tumor cell sensitivity to radiation and chemotherapy by promoting apoptosis and inhibiting cell viability. The gene discussed is BIRC5; the disease is neoplasm.